[Tako-tsubo cardiomyopathy in a patient with hypertrophic cardiomyopathy with obstruction]

Aneta I Gziut1, Elżbieta Piechocka, Tomasz Pawłowski

  • 1Klinika Kardiologii Inwazyjnej, CSK MSWiA, Warszawa. anetagziut@poczta.onet.pl

Kardiologia Polska
|March 21, 2012
PubMed

Insights

A patient experienced chest pain, initially suspected as myocardial infarction. However, diagnostic tests revealed stress-induced cardiomyopathy with left ventricle outflow obstruction, not a typical heart attack.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Medical Diagnostics

Background:

  • A 74-year-old patient presented with chest pain suggestive of Non-ST elevation myocardial infarction following significant stress.
  • Initial suspicion of acute coronary syndrome prompted admission to the Invasive Cardiology Department.

Observation:

  • Coronary angiography revealed normal coronary arteries, ruling out obstructive coronary artery disease.
  • Ventriculography demonstrated apical ballooning and near-complete occlusion of the left ventricle cavity.
  • Echocardiography indicated asymmetric hypertrophy of the heart walls and significant left ventricle outflow tract obstruction.

Findings:

  • The diagnostic workup excluded myocardial infarction and coronary artery disease.
  • Findings were consistent with stress-induced cardiomyopathy (Takotsubo cardiomyopathy) presenting atypically.
  • Cardiac magnetic resonance imaging was considered due to initial suspicion of a cardiac tumor.

Implications:

  • This case highlights the importance of considering stress-induced cardiomyopathy in patients with chest pain and normal coronaries.
  • Accurate diagnosis is crucial for appropriate management and differentiating from other cardiac emergencies.
  • Advanced imaging modalities like cardiac MRI may be necessary for comprehensive evaluation in complex cases.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...